The administration of therapeutic monoclonal antibody to patients can lead to the occurrence of anti-drug antibodies, which can reduce the efficacy of treatment. As more antibody drugs are approved, this is a growing problem that is attracting attention from frontline clinicians. We developed a platform for the detection of IgG anti-drug antibodies for all therapeutic monoclonal antibodies.